Bulletin
Investor Alert

Exact Sciences Corp.

NAS: EXAS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206653925/composite

$

87.35

Change

+1.89 +2.21%

Volume

Volume 7,127

Nov 26, 2021, 3:46 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206653925/composite

Previous close

$ 88.09

$ 85.46

Change

-2.63 -2.99%

Day low

Day high

$85.03

$90.39

Open
Open: 89.16

52 week low

52 week high

$81.07

$159.54

Open

Market cap

$15.18B

Average volume

1.54M

P/E ratio

N/A

Rev. per Employee

$298,278

EPS

-4.98

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/exas

MarketWatch News on EXAS

  1. Exact Sciences downgraded to outperform from strong buy at Raymond James

    8:15 a.m. Nov. 3, 2021

    - Tomi Kilgore

  2. The Man Behind Moderna on What’s Next in Biotech

    10:49 p.m. Oct. 15, 2021

    - Barron's Online

  3. Equipment-Buying Wave Is Coming, and It Should Boost Cisco

    9:15 p.m. Sept. 17, 2021

    - Barron's Online

  4. Will Illumina’s Purchase of Grail Kill Cancer-Test Competition?

    6:49 a.m. Aug. 30, 2021

    - Barron's Online

  5. How Natera Is Defending Its Lead in a $15B Cancer-Testing Market

    9:34 a.m. June 22, 2021

    - Barron's Online

  6. Exact Sciences initiated at strong buy with $160 price target at Raymond James

    6:45 a.m. June 15, 2021

    - Tonya Garcia

  7. Grail Will Begin Selling Its Multi-Cancer Blood Test

    8:10 a.m. June 4, 2021

    - Barron's Online

  8. Exact Sciences stock price target cut to $168 from $226 at Truist

    6:59 a.m. May 12, 2021

    - Tomi Kilgore

  9. ARK Innovation ETF Is Struggling Again—and It May Get Worse

    2:13 p.m. May 6, 2021

    - Barron's Online

  10. How a Simple Blood Test Could Reduce Cancer Deaths

    6:26 a.m. April 12, 2021

    - Barron's Online

  11. The FTC Wants to Block Illumina's Deal for Grail

    7:58 a.m. March 31, 2021

    - Barron's Online

  12. Exact Sciences started at buy with $226 stock price target at Truist

    7:42 a.m. Jan. 28, 2021

    - Tomi Kilgore

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/exas

Other News on EXAS

  1. These 2 Cathie Wood Stocks Are Screaming Buys

    6:50 a.m. Nov. 24, 2021

    - Motley Fool

  2. 3 Beaten-Down Genomics Stocks: Can They Recover?

    6:38 a.m. Nov. 16, 2021

    - Motley Fool

  3. Mainz Biomed more than doubles on trading debut

    10:24 a.m. Nov. 5, 2021

    - Seeking Alpha

  4. Exact Sciences (EXAS) Q3 2021 Earnings Call Transcript

    12:31 a.m. Nov. 3, 2021

    - Motley Fool

  5. Loading more headlines...
/news/pressrelease/company/us/exas

Press Releases on EXAS

  1. Section 32 Raises $740 Million Venture Fund

    7:14 a.m. Nov. 4, 2021

    - PR Newswire - PRF

  2. Exact Sciences announces third quarter 2021 results

    3:05 p.m. Nov. 2, 2021

    - PR Newswire - PRF

  3. Exact Sciences to participate in November investor conferences

    5:00 a.m. Nov. 1, 2021

    - PR Newswire - PRF

  4. MDxHealth Provides Q3-2021 Business Update

    12:00 a.m. Oct. 21, 2021

    - GlobeNewswire

  5. Exact Sciences schedules third quarter 2021 earnings call

    5:00 a.m. Oct. 8, 2021

    - PR Newswire - PRF

  6. Exact Sciences to participate in September investor conferences

    5:00 a.m. Sept. 1, 2021

    - PR Newswire - PRF

  7. Renalytix Appoints Daniel J. Levangie to its Board of Directors

    6:00 a.m. Aug. 30, 2021

    - GlobeNewswire

  8. Molecular Diagnostics Market Size, Share, Trends, Analysis and Forecast 2027

    5:12 a.m. Aug. 25, 2021

    - Market Insight Reports

  9. Global Non-Invasive Liquid Biopsy Market Research Report 2021

    3:23 a.m. Aug. 17, 2021

    - GlobeNewswire

  10. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.